eslicarbazepine acetate has been researched along with Drug-Related Side Effects and Adverse Reactions in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, R; Gama, H; Magalhães, LM; Moreira, J; Soares-da-Silva, P; Vieira, M | 1 |
| Groppa, S; Klimpe, S; Melzer, N; Meuth, SG; Sandner, K; Vieth, TL; Winter, Y | 1 |
| Assenza, G; McMurray, R; Peltola, J; Rocamora, R; Villanueva, V | 1 |
| Brodie, MJ; Stephen, LJ; Wishart, A | 1 |
| Costa, R; Gama, H; Graça, J; Magalhães, LM; Soares-da-Silva, P; Vieira, M | 1 |
| Johnson, EL; Krauss, GL; Kwok, CS | 1 |
| Ahmed, A; Henley, W; Jalihal, V; McLean, BN; Parrett, M; Sander, JW; Shankar, R; Tittensor, P | 1 |
| Blum, D; Fiedler-Kelly, J; Grinnell, T; Ludwig, EA; Passarell, JA; Sunkaraneni, S | 1 |
| Ben-Menachem, E; Blum, D; Carreño, M; Falcão, A; Fiedler-Kelly, J; Gidal, BE; Grinnell, T; Jacobson, MP; Ludwig, E; Moreira, J; Passarell, J; Rocha, F; Soares-da-Silva, P; Sunkaraneni, S | 1 |
| Blum, D; Cheng, H; Chung, S; Grinnell, T; Jung, J; Shah, A; Sinha, SR; Stern, JM | 1 |
| Almeida, L; Elger, C; Halász, P; Maia, J; Soares-da-Silva, P | 1 |
| Almeida, L; Cramer, JA; Członkowska, A; Elger, C; Guekht, A; Halász, P; Hodoba, D; Maia, J; Soares-da-Silva, P | 1 |
2 review(s) available for eslicarbazepine acetate and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Humans; Male; Randomized Controlled Trials as Topic; Safety; Seizures | 2017 |
Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.
Topics: Acetamides; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Follow-Up Studies; Humans; Lacosamide; Longitudinal Studies; Medication Adherence; Nitriles; Product Surveillance, Postmarketing; Pyridones; Pyrrolidinones; Seizures | 2017 |
6 trial(s) available for eslicarbazepine acetate and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience.
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Drug-Related Side Effects and Adverse Reactions; Humans; Hyponatremia; Marketing; Middle Aged; Seizures; Treatment Outcome | 2021 |
Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Headache; Healthy Volunteers; Humans; Hyponatremia; Male; Middle Aged; Models, Biological; Nausea; Seizures; Sodium; Treatment Outcome | 2018 |
Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Seizures | 2018 |
Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Depression; Dibenzazepines; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Longitudinal Studies; Male; Middle Aged; Quality of Life; Seizures; Treatment Outcome; Young Adult | 2019 |
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Partial; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Partial; Epilepsy; Female; Health Status; Humans; Intention to Treat Analysis; Longitudinal Studies; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2010 |
4 other study(ies) available for eslicarbazepine acetate and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Eslicarbazepine Acetate as Adjunctive Therapy for Primary Generalized Tonic-Clonic Seizures in Adults: A Prospective Observational Study.
Topics: Adult; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Myoclonic; Humans; Prospective Studies; Seizures; Sodium Channel Blockers; Treatment Outcome | 2022 |
Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Clinical Studies as Topic; Dibenzazepines; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Oxcarbazepine; Young Adult | 2020 |
Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Fructose; Humans; Lacosamide; Levetiracetam; Male; Medical Audit; Mental Disorders; Middle Aged; Nitriles; Piracetam; Pregabalin; Prospective Studies; Pyridones; Retrospective Studies; Seizures; Sodium Channel Blockers; Topiramate; Young Adult | 2017 |
Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Humans; Levetiracetam; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Seizures; Substance Withdrawal Syndrome; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2018 |